Tag: Survival
Thicker Melanoma Tumor Size Tied to Higher Risk of 20-Year Melanoma-Related Death
Findings for primary tumors of 0.8 to 1.0 mm versus those <0.8 mm
ASH: Blinatumomab + Chemo Aids Survival in B-Cell Acute Lymphoblastic Leukemia
Estimated disease-free survival 97.5 ± 1.3 and 90.2 ± 2.3 percent with chemotherapy plus blinatumomab, chemo alone in average-risk patients
Screening Primary Driver of Averted Cancer Deaths From 1975 to 2020
Authors say further reductions will require new discoveries, adoption of emerging interventions
Adding Pembrolizumab Ups Survival in Stage III Undifferentiated Sarcoma
Benefit seen for stage III undifferentiated pleomorphic sarcoma or dedifferentiated or pleomorphic liposarcoma of the extremity and limb girdles
Smoking Cessation Aids Survival Even Following a Cancer Diagnosis
Maximal survival benefit seen for smoking cessation treatment within six months of diagnosis
Multigene Signature Can Help Tailor Chemo for Operable Triple-Negative Breast Cancer
Improved three-year disease-free and recurrence-free survival seen with intensive chemotherapy regimen
Artificial Intelligence Model Predicts Kidney Graft Survival
UK-DTOP model shows marked improvement compared with traditional Kidney Donor Risk Index
Pembrolizumab Aids Survival With High-Risk Endometrial Cancer
Findings seen in combination with chemotherapy following surgery in patients with curative intent
Many More Lives Could Have Been Saved With Convalescent COVID-19 Plasma
Per a recent study, ideal CCP use could have saved 234,869 lives and prevented 1,136,133 hospitalizations
Progression-Free Survival Improved With Nivolumab + AVD in Hodgkin Lymphoma
Longer progression-free survival seen with nivolumab + doxorubicin, vinblastine, and dacarbazine (AVD) versus brentuximab vedotin + AVD
